Showing results (481-490 of 618) with videos related to

Sort By:
Pageof 62
Revue Medicale De Liege|March 9, 2018
[Lower limb oedema in a patient with type 2 diabetes]A J Scheen, N Paquot, P Lancellotti, et al.
Revue Medicale De Liege|June 26, 2008
[How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system]F Schleich, J M Krzesinski, L Piérard, et al.
Diabetes & Metabolism|April 18, 2015
Individualizing treatment of type 2 diabetes by targeting postprandial or fasting hyperglycaemia: Response to a basal vs a premixed insulin regimen by HbA1c quartiles and ethnicityA J Scheen, H Schmitt, H H Jiang, et al.
The American Journal of Physiology|November 1, 1989
Effects of pulsatile delivery of insulin and glucagon in humansG Paolisso, A J Scheen, A Albert, et al.
Diabetes Care|November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruptionA J Scheen, P Henrivaux, B Jandrain, et al.
Diabete & Metabolisme|January 1, 1988
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal manN Paquot, A J Scheen, P Franchimont, et al.
Acta Endocrinologica|November 1, 1987
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretionM Castillô, A J Scheen, G Paolisso, et al.
Revue Medicale De Liege|May 17, 2002
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]A J Scheen, N Paquot, B Jandrain, et al.
Revue Medicale De Liege|April 7, 2017
[Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER]A J Scheen, L Piérard, J-M Krzesinski, et al.
Revue Medicale De Liege|March 22, 2019
[Management of hypertriglyceridaemia]A J Scheen, C Wallemacq, J De Flines, et al.
Pageof 62